These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12012011)

  • 1. Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review).
    Crucitta E; Fornier MN; Locopo N; Silvestris N; Lorusso V; De Lena M
    Int J Oncol; 2002 Jun; 20(6):1283-8. PubMed ID: 12012011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exemestane: a review of its use in postmenopausal women with advanced breast cancer.
    Clemett D; Lamb HM
    Drugs; 2000 Jun; 59(6):1279-96. PubMed ID: 10882163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exemestane: a novel aromatase inactivator for breast cancer.
    Jones SA; Jones SE
    Clin Breast Cancer; 2000 Oct; 1(3):211-6. PubMed ID: 11899645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of aromatase inactivators in the treatment of breast cancer.
    Lønning PE
    Int J Clin Oncol; 2002 Aug; 7(4):265-70. PubMed ID: 12202980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatment.
    Dixon JM
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):267-75. PubMed ID: 12113050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'.
    Atalay G; Dirix L; Biganzoli L; Beex L; Nooij M; Cameron D; Lohrisch C; Cufer T; Lobelle JP; Mattiaci MR; Piccart M; Paridaens R
    Ann Oncol; 2004 Feb; 15(2):211-7. PubMed ID: 14760111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exemestane: a review of its use in postmenopausal women with breast cancer.
    Deeks ED; Scott LJ
    Drugs; 2009; 69(7):889-918. PubMed ID: 19441873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exemestane in postmenopausal women with early or advanced breast cancer: a review.
    Bertelli G; Gangadhara S
    Expert Opin Pharmacother; 2010 Aug; 11(11):1933-42. PubMed ID: 20569090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-aromatase agents in the treatment and prevention of breast cancer.
    Goss P
    Cancer Control; 2002; 9(2 Suppl):2-8. PubMed ID: 11965225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exemestane: new preparation. No tangible advance in metastatic breast cancer after tamoxifen failure.
    Prescrire Int; 2001 Aug; 10(54):108-9. PubMed ID: 11718178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and clinical experience with exemestane.
    Lønning PE
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1897-905. PubMed ID: 11060785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exemestane in breast cancer: current status and future directions.
    Lønning PE
    Clin Breast Cancer; 2000 Sep; 1 Suppl 1():S28-33. PubMed ID: 11970747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exemestane in advanced breast cancer.
    Buzdar A
    Anticancer Drugs; 2000 Sep; 11(8):609-16. PubMed ID: 11081451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal and steroidal aromatase inhibitors in breast cancer.
    Hamilton A; Volm M
    Oncology (Williston Park); 2001 Aug; 15(8):965-72; discussion 972, 977-9. PubMed ID: 11548977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of aromasin in the hormonal therapy of breast cancer.
    Dank M
    Pathol Oncol Res; 2002; 8(2):87-92. PubMed ID: 12172571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exemestane experience in breast cancer treatment.
    Lønning PE; Paridaens R; Thürlimann B; Piscitelli G; di Salle E
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):151-5. PubMed ID: 9365185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exemestane.
    Scott LJ; Wiseman LR
    Drugs; 1999 Oct; 58(4):675-80; discussion 681-2. PubMed ID: 10551437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane.
    Buzdar AU; Robertson JF; Eiermann W; Nabholtz JM
    Cancer; 2002 Nov; 95(9):2006-16. PubMed ID: 12404296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. Aromasin Study Group.
    Jones S; Vogel C; Arkhipov A; Fehrenbacher L; Eisenberg P; Cooper B; Honig S; Polli A; Whaley F; di Salle E; Tiffany J; Consonni A; Miller L
    J Clin Oncol; 1999 Nov; 17(11):3418-25. PubMed ID: 10550136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitors for therapy of advanced breast cancer.
    Ingle JN; Suman VJ
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):113-9. PubMed ID: 15939585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.